TW201824962A - A target and neutron capture treatment system that is used for neutron line to produce device - Google Patents
A target and neutron capture treatment system that is used for neutron line to produce device Download PDFInfo
- Publication number
- TW201824962A TW201824962A TW106128754A TW106128754A TW201824962A TW 201824962 A TW201824962 A TW 201824962A TW 106128754 A TW106128754 A TW 106128754A TW 106128754 A TW106128754 A TW 106128754A TW 201824962 A TW201824962 A TW 201824962A
- Authority
- TW
- Taiwan
- Prior art keywords
- neutron
- target
- active layer
- layer
- generating device
- Prior art date
Links
- 239000002245 particle Substances 0.000 claims abstract description 41
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 238000005187 foaming Methods 0.000 claims abstract description 11
- 238000007493 shaping process Methods 0.000 claims abstract description 9
- 238000001816 cooling Methods 0.000 claims description 71
- 239000000463 material Substances 0.000 claims description 49
- 230000017525 heat dissipation Effects 0.000 claims description 38
- 230000005855 radiation Effects 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 12
- 230000009471 action Effects 0.000 claims description 10
- 239000006096 absorbing agent Substances 0.000 claims description 9
- 239000000956 alloy Substances 0.000 claims description 9
- 229910052715 tantalum Inorganic materials 0.000 claims description 9
- 239000013077 target material Substances 0.000 claims description 9
- 229910001080 W alloy Inorganic materials 0.000 claims description 8
- 229910045601 alloy Inorganic materials 0.000 claims description 8
- 229910052782 aluminium Inorganic materials 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 6
- 230000000996 additive effect Effects 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000006260 foam Substances 0.000 claims description 6
- 239000004020 conductor Substances 0.000 claims description 5
- 230000008020 evaporation Effects 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 5
- 238000004544 sputter deposition Methods 0.000 claims description 5
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 238000005266 casting Methods 0.000 claims description 2
- 238000011161 development Methods 0.000 claims description 2
- 239000006261 foam material Substances 0.000 claims 1
- 230000000979 retarding effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 230000006872 improvement Effects 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 148
- 239000002826 coolant Substances 0.000 description 29
- 230000003064 anti-oxidating effect Effects 0.000 description 21
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 10
- 229910052796 boron Inorganic materials 0.000 description 10
- 229910052744 lithium Inorganic materials 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 10
- 210000004881 tumor cell Anatomy 0.000 description 8
- 239000010949 copper Substances 0.000 description 6
- 238000001513 hot isostatic pressing Methods 0.000 description 6
- 229910052721 tungsten Inorganic materials 0.000 description 6
- 230000001133 acceleration Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229910052790 beryllium Inorganic materials 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- -1 for example Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 2
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 229910016569 AlF 3 Inorganic materials 0.000 description 1
- 229910000851 Alloy steel Inorganic materials 0.000 description 1
- 229910004261 CaF 2 Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000009201 electron therapy Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 229910001338 liquidmetal Inorganic materials 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000002139 neutron reflectometry Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000002727 particle therapy Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 238000002661 proton therapy Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Particle Accelerators (AREA)
Abstract
Description
本發明一方面係關於一種用於輻射線照射系統的靶材,特別是有關於一種用於粒子線產生裝置的靶材;本發明另一方面係關於一種輻射線照射系統,特別是有關於一種中子捕獲治療系統。 One aspect of the present invention relates to a target used in a radiation irradiation system, and particularly to a target used in a particle radiation generating device; another aspect of the present invention relates to a radiation irradiation system, and more particularly, to a radiation irradiation system. Neutron Capture Therapy System.
隨著原子科學的發展,例如鈷六十、直線加速器、電子射束等放射線治療已成為癌症治療的主要手段之一。然而傳統光子或電子治療受到放射線本身物理條件的限制,在殺死腫瘤細胞的同時,也會對射束途徑上大量的正常組織造成傷害;另外由於腫瘤細胞對放射線敏感程度的不同,傳統放射治療對於較具抗輻射性的惡性腫瘤(如:多行性膠質母細胞瘤(glioblastoma multiforme)、黑色素細胞瘤(melanoma))的治療成效往往不佳。 With the development of atomic science, radiation therapy such as cobalt sixty, linear accelerator, electron beam has become one of the main means of cancer treatment. However, traditional photon or electron therapy is limited by the physical conditions of the radiation itself. While killing tumor cells, it will also cause damage to a large number of normal tissues in the beam path. In addition, due to the different sensitivity of tumor cells to radiation, traditional radiation therapy Treatment of radiation-resistant malignancies (eg, glioblastoma multiforme, melanoma) is often not effective.
為了減少腫瘤周邊正常組織的輻射傷害,化學治療(chemotherapy)中的標靶治療概念便被應用於放射線治療中;而針對高抗輻射性的腫瘤細胞,目前也積極發展具有高相對生物效應(relative biological effectiveness,RBE)的輻射源,如質子治療、重粒子治療、中子捕獲治療等。其中,中子捕獲治療便是結合上述兩種概念,如硼中子捕獲治療,借由含硼藥物在腫瘤細胞的特異性集聚,配合精準的中子射束調 控,提供比傳統放射線更好的癌症治療選擇。 In order to reduce radiation damage to normal tissues surrounding tumors, the concept of target therapy in chemotherapy has been applied to radiation therapy. At the same time, tumor cells with high radiation resistance have also been actively developed with high relative biological effects. biological effectiveness (RBE) radiation sources, such as proton therapy, heavy particle therapy, neutron capture therapy, etc. Among them, neutron capture therapy is a combination of the above two concepts, such as boron neutron capture therapy, which uses boron-containing drugs to specifically accumulate in tumor cells and cooperates with precise neutron beam regulation to provide better than traditional radiation. Cancer treatment options.
在加速器硼中子捕獲治療中,加速器硼中子捕獲治療通過加速器將質子束加速,質子束加速至足以克服靶材原子核庫倫斥力的能量,與靶材發生核反應以產生中子,如何提高中子產率以獲得足夠的中子用於治療是系統設計中的核心問題。 In the accelerator boron neutron capture therapy, the accelerator boron neutron capture therapy accelerates the proton beam through the accelerator, which accelerates the proton beam to an energy sufficient to overcome the Coulomb repulsive force of the target atomic nucleus to generate a neutron with the target to generate neutrons. Productivity to obtain sufficient neutrons for treatment is a core issue in system design.
因此,有必要提出一種新的技術方案以解決上述問題。 Therefore, it is necessary to propose a new technical solution to solve the above problems.
為了解決上述問題,本發明一方面提供了一種用於中子線產生裝置的靶材,其包括作用層和基座層,作用層能夠與入射粒子線作用產生中子線,基座層既能抑制由入射粒子線引起的發泡又能支撐作用層,作用層包括第一作用層和第二作用層,入射粒子線沿入射方向依次穿過第一作用層和第二作用層。採用沿粒子線入射方向設置的第一作用層和第二作用層,能夠增加中子產率。 In order to solve the above problems, one aspect of the present invention is to provide a target for a neutron generating device, which includes an active layer and a base layer, and the active layer can interact with the incident particle line to generate a neutron line. The suppression of the foam caused by the incident particle line can also support the action layer. The action layer includes a first action layer and a second action layer, and the incident particle line passes through the first action layer and the second action layer in order along the incident direction. The use of the first active layer and the second active layer provided along the incident direction of the particle line can increase the neutron yield.
第一、第二作用層的材料均為能夠與入射粒子線發生核反應的材料,第一、第二作用層的材料不同。 The materials of the first and second active layers are all materials capable of undergoing a nuclear reaction with the incident particle rays, and the materials of the first and second active layers are different.
第一作用層的材料為Be或其合金,第二作用層的材料為Li或其合金,入射粒子線為質子線,第一、第二作用層分別與質子線發生9Be(p,n)9B及7Li(p,n)7Be核反應來產生中子,質子線的能量為2.5MeV-5MeV,中子產率為7.31E-05 n/proton-5.61E-04 n/proton。採用Be或其合金作為第一作用層,能夠防止第一、第二作用層被氧化,不易被第二作用層腐蝕且能夠減小入射質子束的損耗及質子束導致的發熱,同時能夠與質子發生核反應,進一步地增加中子產率。 The material of the first active layer is Be or its alloy, the material of the second active layer is Li or its alloy, the incident particle line is a proton line, and the first and second active layers generate 9 Be (p, n) with the proton line, respectively. 9 B and 7 Li (p, n) 7 Be nuclear reactions to generate neutrons, the energy of the protons is 2.5MeV-5MeV, and the neutron yield is 7.31E-05 n / proton-5.61E-04 n / proton. Using Be or its alloy as the first active layer can prevent the first and second active layers from being oxidized, is not easy to be corroded by the second active layer, and can reduce the loss of incident proton beams and the heat generated by the proton beams. A nuclear reaction occurs, further increasing the neutron yield.
第一作用層的厚度為5μm-25μm,第二作用層的厚度為80μm-240μm。 The thickness of the first active layer is 5 μm -25 μm , and the thickness of the second active layer is 80 μm -240 μm .
第二作用層與基座層通過澆注、蒸鍍或濺射工藝連接,第一作用層通過HIP處理將基座層封閉形成一個容腔和/或將第二作用層包圍。 The second active layer is connected to the base layer through a casting, evaporation or sputtering process, and the first active layer closes the base layer to form a cavity and / or surrounds the second active layer through a HIP process.
第二作用層和基座層之間設置附著層,附著層的材料包括Cu、Al、Mg或Zn中的至少一種。 An adhesion layer is provided between the second active layer and the base layer, and the material of the adhesion layer includes at least one of Cu, Al, Mg, or Zn.
本發明之用於中子線產生裝置的靶材還包括散熱層,散熱層包括冷卻通道,冷卻通道是通過增材製造形成的。散熱層具有冷卻通道,提升了散熱效果,有助於延長靶材的壽命。 The target material for the neutron generating device of the present invention further includes a heat dissipation layer including a cooling channel, and the cooling channel is formed by additive manufacturing. The heat dissipation layer has cooling channels, which improves the heat dissipation effect and helps to extend the life of the target.
基座層由抑制發泡的材料製成,散熱層由導熱材料或既能導熱又能抑制發泡的材料製成,抑制發泡的材料或既能導熱又能抑制發泡的材料包括Fe、Ta或V中的至少一種,導熱材料包括Cu、Fe、Al中的至少一種,散熱層和基座層通過HIP工藝連接。 The base layer is made of a material that suppresses foaming, the heat dissipation layer is made of a thermally conductive material or a material that can both conduct heat and foam, and a material that suppresses foaming or a material that can both conduct heat and foam includes Fe, At least one of Ta or V, the thermally conductive material includes at least one of Cu, Fe, and Al, and the heat dissipation layer and the base layer are connected by a HIP process.
散熱層和基座層至少部分為相同的材料或是一體的,相同的材料為Ta或Ta-W合金。 The heat dissipation layer and the base layer are at least partially made of the same material or integrated, and the same material is Ta or Ta-W alloy.
本發明另一方面提供了一種中子捕獲治療系統,其包括中子產生裝置和射束整形體,中子產生裝置包括加速器和靶材,加速器加速產生的帶電粒子線與靶材作用產生中子線,射束整形體包括反射體、緩速體、熱中子吸收體、輻射屏蔽體和射束出口,緩速體將自靶材產生的中子減速至超熱中子能區,反射體包圍緩速體並將偏離的中子導回至緩速體以提高超熱中子射束強度,熱中子吸收體用於吸收熱中子以避免治療時與淺 層正常組織造成過多劑量,輻射屏蔽體圍繞射束出口設置在反射體後部用於屏蔽滲漏的中子和光子以減少非照射區的正常組織劑量,該靶材如上述。 Another aspect of the present invention provides a neutron capture therapy system, which includes a neutron generating device and a beam shaper. The neutron generating device includes an accelerator and a target. The charged particle beam generated by the accelerator accelerates to generate a neutron by interacting with the target. The beam shaping body includes a reflector, a retarder, a thermal neutron absorber, a radiation shield, and a beam exit. The retarder reduces the neutrons generated from the target material to the superheated neutron energy region, and the reflector surrounds the retarder. The neutron is deflected and the deviated neutron is returned to the retarder to increase the intensity of the superheated neutron beam. The thermal neutron absorber is used to absorb thermal neutrons to avoid excessive doses with shallow normal tissue during treatment. The beam exit is arranged at the rear of the reflector for shielding leaked neutrons and photons to reduce the normal tissue dose in the non-irradiated area. The target is as described above.
本發明實施例之靶材,其作用層包括第一作用層和第二作用層,入射粒子線沿入射方向依次穿過第一作用層和第二作用層。採用沿粒子線入射方向設置的第一作用層和第二作用層,能夠增加中子產率。 In the target of the embodiment of the present invention, the active layer includes a first active layer and a second active layer, and an incident particle line passes through the first active layer and the second active layer in order along the incident direction. The use of the first active layer and the second active layer provided along the incident direction of the particle line can increase the neutron yield.
100‧‧‧硼中子捕獲治療裝置 100‧‧‧ Boron Neutron Capture Therapy Device
10‧‧‧中子產生裝置 10‧‧‧ Neutron Generator
11‧‧‧加速器 11‧‧‧ accelerator
111‧‧‧加速管 111‧‧‧Accelerator
12‧‧‧散熱層 12‧‧‧ heat dissipation layer
121‧‧‧管狀件 121‧‧‧Tube
122‧‧‧支撐件 122‧‧‧Support
1221‧‧‧第一支撐部 1221‧‧‧First support
1222‧‧‧第二支撐部 1222‧‧‧Second support
1223‧‧‧第三支撐部 1223‧‧‧third support
123‧‧‧突出部 123‧‧‧ protrusion
124‧‧‧第二壁 124‧‧‧Second Wall
13‧‧‧基座層 13‧‧‧ base layer
14‧‧‧作用層 14‧‧‧action layer
15‧‧‧抗氧化層 15‧‧‧anti-oxidation layer
16‧‧‧附著層 16‧‧‧ Adhesive layer
17‧‧‧連接部 17‧‧‧ Connection Department
20‧‧‧射束整形體 20‧‧‧ Beam Shaping Body
21‧‧‧反射體 21‧‧‧Reflector
22‧‧‧緩速體 22‧‧‧ Slow body
23‧‧‧熱中子吸收體 23‧‧‧ thermal neutron absorber
24‧‧‧輻射屏蔽體 24‧‧‧ Radiation Shield
25‧‧‧射束出口 25‧‧‧ Beam exit
30‧‧‧準直器 30‧‧‧ Collimator
40‧‧‧治療台 40‧‧‧Treatment Table
50‧‧‧輻射屏蔽裝置 50‧‧‧ radiation shielding device
51‧‧‧醫學影像掃描裝置 51‧‧‧ medical image scanning device
52‧‧‧資料處理及三維建模裝置 52‧‧‧Data processing and 3D modeling device
53‧‧‧屏蔽體 53‧‧‧shield
531‧‧‧中心通孔 531‧‧‧ center through hole
200‧‧‧患者 200‧‧‧patients
T‧‧‧靶材 T‧‧‧Target
C‧‧‧帶電粒子線 C‧‧‧ Charged Particle Line
N‧‧‧中子線 N‧‧‧neutron
M‧‧‧腫瘤細胞 M‧‧‧ tumor cells
P‧‧‧冷卻通道 P‧‧‧ cooling channel
P1‧‧‧第一冷卻通道 P1‧‧‧first cooling channel
P2‧‧‧第二冷卻通道 P2‧‧‧Second cooling channel
P3‧‧‧第三冷卻通道 P3‧‧‧third cooling channel
IN‧‧‧冷卻進口 IN‧‧‧Cooling inlet
OUT‧‧‧冷卻出口 OUT‧‧‧cooling outlet
D1‧‧‧第一冷卻管 D1‧‧‧The first cooling pipe
D2‧‧‧第二冷卻管 D2‧‧‧Second cooling pipe
S‧‧‧冷卻表面 S‧‧‧ cooling surface
W‧‧‧內壁 W‧‧‧Inner wall
D‧‧‧冷卻介質流通方向 D‧‧‧Cooling medium circulation direction
P'、P"‧‧‧子通道 P ', P "‧‧‧ subchannel
圖1為本發明實施例中的中子捕獲治療系統示意圖。 FIG. 1 is a schematic diagram of a neutron capture therapy system in an embodiment of the present invention.
圖2為本發明實施例中的靶材的示意圖。 FIG. 2 is a schematic diagram of a target in an embodiment of the present invention.
圖3為圖2中的靶材的局部放大示意圖。 FIG. 3 is a partially enlarged schematic view of the target in FIG. 2.
圖4為圖2中的靶材的散熱層從方向A看過去的示意圖。 FIG. 4 is a schematic view of the heat dissipation layer of the target in FIG. 2 viewed from the direction A. FIG.
圖5a為圖2中的靶材的散熱通道內壁的第一實施例的示意圖。 FIG. 5 a is a schematic diagram of a first embodiment of an inner wall of a heat dissipation channel of the target in FIG. 2.
圖5b為圖2中的靶材的散熱通道內壁的第一實施例的沿軸線 B-B的示意圖。 Fig. 5b is a schematic view along the axis B-B of the first embodiment of the inner wall of the heat dissipation channel of the target in Fig. 2.
圖6a為圖2中的靶材的散熱通道內壁的第二實施例的示意圖。 FIG. 6 a is a schematic diagram of a second embodiment of the inner wall of the heat dissipation channel of the target in FIG. 2.
圖6b為圖2中的靶材的散熱通道內壁的第二實施例的沿軸線 C-C的示意圖。 Fig. 6b is a schematic view along the axis C-C of the second embodiment of the inner wall of the heat dissipation channel of the target in Fig. 2.
圖7為圖2中的靶材的散熱通道內壁的第三實施例的示意圖。 FIG. 7 is a schematic diagram of a third embodiment of the inner wall of the heat dissipation channel of the target in FIG. 2.
下面結合附圖對本發明實施例做進一步的詳細說明,以令本領域技術人員參照說明書文字能夠據以實施。 The embodiments of the present invention are further described in detail below with reference to the accompanying drawings, so that those skilled in the art can implement the present invention with reference to the description text.
如圖1,本實施例中的中子捕獲治療系統優選為硼中子捕獲治療系統100,包括中子產生裝置10、射束整形體20、準直器30和治療台40。中子產生裝置10包括加速器11和靶材T,加速器11對帶電粒子(如質子、氘核等)進行加速,產生如質子線的帶電粒子線C,帶電粒子線C照射到靶材T並與靶材T作用產生中子線(中子束)N,靶材T優選為金屬靶材。依據所需的中子產率與能量、可提供的加速帶電粒子能量與電流大小、金屬靶材的物化性等特性來挑選合適的核反應,常被討論的核反應有7Li(p,n)7Be及9Be(p,n)9B,這兩種反應皆為吸熱反應。兩種核反應的能量閾值分別為1.881MeV和2.055MeV,由於硼中子捕獲治療的理想中子源為keV能量等級的超熱中子,理論上若使用能量僅稍高於閾值的質子轟擊金屬鋰靶材,可產生相對低能的中子,不需太多的緩速處理便可用於臨床,然而鋰金屬(Li)和鈹金屬(Be)兩種靶材與閾值能量的質子作用截面不高,為產生足夠大的中子通量,通常選用較高能量的質子來引發核反應。理想的靶材應具備高中子產率、產生的中子能量分佈接近超熱中子能區(將在下文詳細描述)、無太多強穿輻射產生、安全便宜易於操作且耐高溫等特性,但實際上並無法找到符合所有要求的核反應。本領域技術人員熟知的,靶材T也可以由Li、Be之外的金屬材料製成,例如由Ta或W及其合金等形成。加速器11可以是直線加速器、迴旋加速器、同步加速器、同步迴旋加速器。 As shown in FIG. 1, the neutron capture treatment system in this embodiment is preferably a boron neutron capture treatment system 100, which includes a neutron generation device 10, a beam shaper 20, a collimator 30, and a treatment table 40. The neutron generating device 10 includes an accelerator 11 and a target T. The accelerator 11 accelerates charged particles (such as protons, deuterons, etc.) to generate charged particle lines C such as proton lines. The charged particle lines C are irradiated to the target T and interact with the target T. The target T generates a neutron (neutron beam) N, and the target T is preferably a metal target. Select the appropriate nuclear reaction based on the required neutron yield and energy, the energy and current available for the accelerated charged particles, and the physical and chemical properties of the metal target. The nuclear reactions that are often discussed are 7 Li (p, n) 7 Be and 9 Be (p, n) 9 B, these two reactions are endothermic reactions. The energy thresholds of the two nuclear reactions are 1.881 MeV and 2.055 MeV, respectively. Since the ideal neutron source for boron neutron capture therapy is super thermal neutrons of keV energy level, theoretically, if a proton with an energy slightly higher than the threshold is used to bombard a lithium metal target Materials, which can generate relatively low-energy neutrons, can be used in the clinic without too much slow-speed treatment. However, the lithium metal (Li) and beryllium metal (Be) targets and threshold energy proton interaction cross sections are not high. To generate a sufficiently large neutron flux, higher energy protons are usually used to initiate the nuclear reaction. The ideal target should have high neutron yield, neutron energy distribution close to the superthermal neutron energy region (described in detail below), no too much strong penetrating radiation, safe and cheap, easy to operate, and high temperature resistance. It is not actually possible to find a nuclear reaction that meets all requirements. As is well known to those skilled in the art, the target T may also be made of a metal material other than Li and Be, for example, Ta or W and an alloy thereof. The accelerator 11 may be a linear accelerator, a cyclotron, a synchrotron, or a synchrocyclotron.
中子產生裝置10產生的中子束N依次通過射束整形體20和 準直器30照射向治療台40上的患者200。射束整形體20能夠調整中子產生裝置10產生的中子束N的射束品質,準直器30用以會聚中子束N,使中子束N在進行治療的過程中具有較高的靶向性。射束整形體20進一步包括反射體21、緩速體22、熱中子吸收體23、輻射屏蔽體24和射束出口25,中子產生裝置10生成的中子由於能譜很廣,除了超熱中子滿足治療需要以外,需要盡可能的減少其他種類的中子及光子含量以避免對操作人員或患者造成傷害,因此從中子產生裝置10出來的中子需要經過緩速體22將其中的快中子能量調整到超熱中子能區,緩速體22由與快中子作用截面大、超熱中子作用截面小的材料製成,本實施例中,緩速體22由D2O、AlF3、Fluental、CaF2、Li2CO3、MgF2和Al2O3中的至少一種製成;反射體21包圍緩速體22,並將穿過緩速體22向四周擴散的中子反射回中子射束N以提高中子的利用率,由具有中子反射能力強的材料製成,本實施例中,反射體21由Pb或Ni中的至少一種製成;緩速體22後部有一個熱中子吸收體23,由與熱中子作用截面大的材料製成,本實施例中,熱中子吸收體23由Li-6製成,熱中子吸收體23用於吸收穿過緩速體22的熱中子以減少中子束N中熱中子的含量,避免治療時與淺層正常組織造成過多劑量;輻射屏蔽體24圍繞射束出口25設置在反射體後部,用於屏蔽從射束出口25以外部分滲漏的中子和光子,輻射屏蔽體24的材料包括光子屏蔽材料和中子屏蔽材料中的至少一種,本實施例中,輻射屏蔽體24的材料包括光子屏蔽材料鉛(Pb)和中子屏蔽材料聚乙烯(PE)。可以理解,射束整形體20還可以有其他的構造,只要能夠獲得治療所需超熱中子束即可。準直器30設置在射束出口25後部,從準直器30出來的超熱中子束向患者200照射,經淺層正常組織 後被緩速為熱中子到達腫瘤細胞M,可以理解,準直器30也可以取消或由其他結構代替,中子束從射束出口25出來直接向患者200照射。本實施例中,患者200和射束出口25之間還設置了輻射屏蔽裝置50,屏蔽從射束出口25出來的射束對患者正常組織的輻射,可以理解,也可以不設置輻射屏蔽裝置50。 The neutron beam N generated by the neutron generator 10 is irradiated to the patient 200 on the treatment table 40 through the beam shaper 20 and the collimator 30 in this order. The beam shaper 20 can adjust the beam quality of the neutron beam N generated by the neutron generating device 10, and the collimator 30 is used to converge the neutron beam N, so that the neutron beam N has a higher quality during the treatment process. Targeting. The beam shaping body 20 further includes a reflector 21, a retarder 22, a thermal neutron absorber 23, a radiation shield 24, and a beam exit 25. The neutrons generated by the neutron generator 10 have a wide energy spectrum, except for superheated In addition to neutrons meeting treatment needs, other types of neutrons and photons need to be reduced as much as possible to avoid harm to the operator or the patient. Therefore, the neutrons from the neutron generating device 10 need to pass the retarder 22 to quickly neutralize them. The neutron energy is adjusted to the superthermal neutron energy region. The retarder 22 is made of a material having a large cross-section with fast neutrons and a small cross-section with superthermal neutrons. In this embodiment, the retarder 22 is made of D 2 O, AlF 3 , Fluental, CaF 2 , Li 2 CO 3 , MgF 2 and Al 2 O 3 ; the reflector 21 surrounds the retarder 22 and reflects back the neutrons diffused through the retarder 22 to the surroundings The neutron beam N is used to improve the utilization rate of neutrons. It is made of a material with strong neutron reflection ability. In this embodiment, the reflector 21 is made of at least one of Pb or Ni; A thermal neutron absorber 23 made of a material with a large cross section acting on the thermal neutron In this embodiment, the thermal neutron absorber 23 is made of Li-6. The thermal neutron absorber 23 is used to absorb the thermal neutrons passing through the retarder 22 to reduce the content of thermal neutrons in the neutron beam N and avoid treatment. Excessive dose is caused by shallow and normal tissues; the radiation shield 24 is arranged around the beam exit 25 at the rear of the reflector to shield neutrons and photons leaking from the part outside the beam exit 25. The material of the radiation shield 24 includes At least one of a photon shielding material and a neutron shielding material. In this embodiment, the material of the radiation shielding body 24 includes a photon shielding material lead (Pb) and a neutron shielding material polyethylene (PE). It can be understood that the beam shaper 20 may have other structures as long as the superheated neutron beam required for treatment can be obtained. The collimator 30 is arranged at the rear of the beam exit 25. The superheated neutron beam coming out of the collimator 30 is irradiated to the patient 200. After passing through the shallow normal tissue, it is slowed down to reach the tumor cell M by thermal neutrons. It can be understood that the collimator The device 30 can also be eliminated or replaced by other structures, and the neutron beam exits the beam exit 25 and directly irradiates the patient 200. In this embodiment, a radiation shielding device 50 is further provided between the patient 200 and the beam exit 25 to shield the radiation from the beam exiting the beam exit 25 to the normal tissue of the patient. It is understood that the radiation shielding device 50 may not be provided. .
患者200服用或注射含硼(B-10)藥物後,含硼藥物選擇性地聚集在腫瘤細胞M中,然後利用含硼(B-10)藥物對熱中子具有高捕獲截面的特性,借由10B(n,α)7Li中子捕獲及核分裂反應產生4He和7Li兩個重荷電粒子。兩荷電粒子的平均能量約為2.33MeV,具有高線性轉移(Linear Energy Transfer,LET)、短射程特徵,α短粒子的線性能量轉移與射程分別為150keV/μm、8μm,而7Li重荷粒子則為175keV/μm、5μm,兩粒子的總射程約相當於一個細胞大小,因此對於生物體造成的輻射傷害能局限在細胞層級,便能在不對正常組織造成太大傷害的前提下,達到局部殺死腫瘤細胞的目的。 After taking or injecting a boron-containing (B-10) drug to patient 200, the boron-containing drug selectively accumulates in tumor cells M, and then the boron-containing (B-10) drug has a characteristic of high capture cross-section for thermal neutrons. The 10 B (n, α) 7 Li neutron capture and nuclear fission reactions produce two heavily charged particles, 4 He and 7 Li. The average energy of two charged particles is about 2.33MeV, having a high linear transfer (Linear Energy Transfer, LET), short-range features, linear energy α shorter particle transfer and range were 150keV / μm, 8μm, and 7 Li heavy charged particles is 175keV / μm, 5μm, the total range of the two particles is about the size of a cell, so the radiation damage to the organism can be limited to the cell level, and it can achieve local killing without causing too much damage to normal tissues. Purpose of dead tumor cells.
下面結合圖2、圖3和圖4對靶材T的結構做詳細的說明。 The structure of the target T will be described in detail below with reference to FIGS. 2, 3 and 4.
靶材T設置在加速器11和射束整形體20之間,加速器11具有對帶電粒子線C進行加速的加速管111,本實施例中,加速管111沿帶電粒子線C方向伸入射束整形體20,並依次穿過反射體21和緩速體22,靶材T設置在緩速體22內並位於加速管111的端部,以得到較好的中子射束品質。 The target T is disposed between the accelerator 11 and the beam shaping body 20. The accelerator 11 has an acceleration tube 111 that accelerates the charged particle line C. In this embodiment, the acceleration tube 111 extends the incident beam shaping along the direction of the charged particle line C. The body 20 passes through the reflector 21 and the retarder 22 in this order. The target T is disposed in the retarder 22 and located at the end of the acceleration tube 111 to obtain better neutron beam quality.
靶材T包括散熱層12、基座層13和作用層14,作用層14與帶電粒子線C作用產生中子線,基座層13支撐作用層14。本實施例中,作 用層14的材料為Li或其合金,帶電粒子線C為質子線,靶材T還包括位於作用層14一側用於防止作用層氧化的抗氧化層15,基座層13能同時抑制由入射質子線引起的發泡,帶電粒子線C沿入射方向依次穿過抗氧化層15、作用層14和基座層13。抗氧化層15的材料同時考慮不易被作用層腐蝕且能夠減小入射質子束的損耗及質子束導致的發熱,如包括Al、Ti及其合金或者不銹鋼中的至少一種。本實施例中,抗氧化層15為同時能夠與質子發生核反應的材料,起到上述作用的同時能進一步地增加中子產率,此時,抗氧化層同時為作用層的一部分,如採用Be或其合金,入射質子束的能量高於與Li和Be發生核反應的能量閾值,分別產生兩種不同的核反應,7Li(p,n)7Be及9Be(p,n)9B;另外,Be具有高熔點及良好的導熱特性,其熔點為1287℃,熱傳導率為201W/(m K),相對於Li(熔點為181℃,熱傳導率為71W/(m K))的耐高溫及散熱性能具有極大優勢,進一步增加了靶材的壽命,並且其與質子發生(p,n)核反應的反應閾值約為2.055MeV,多數採用質子射束的加速器中子源,其能量皆高於該反應閾值,而鈹靶亦是鋰靶以外的最佳選擇。與採用其他材料,如Al,的抗氧化層相比,由於Be的存在,中子產率得到了提高。本實施例中,質子線能量為2.5MeV-5MeV,能夠與鋰靶產生較高的作用截面,同時不會產生過多的快中子,獲得較好的射束品質;作用層14的厚度為80μm-240μm,與質子能發生充分的反應,也不會過厚造成能量沉積,影響靶材散熱性能;在達到上述效果的同時保證較低的製造成本,抗氧化層15的厚度為5μm-25μm。在對比試驗中,採用蒙地卡羅軟體分別模擬2.5MeV、3MeV、3.5MeV、4MeV、4.5MeV、5MeV的質子束由垂直於靶材T的作用表面的方向依次射入抗氧化 層15、作用層14(Li)及基座層13(Ta,將在後文詳述),抗氧化層15的材料以Al與Be進行對比,抗氧化層15厚度分別為5μm、10μm、15μm、20μm、25μm,作用層14厚度分別為80μm、120μm、160μm、200μm、240μm,基座層12厚度對中子產率幾乎沒有影響可視實際情況調整,得到的中子產率(即每個質子產生的中子個數)結果如表1、表2所示。使用Be作為鋰靶抗氧化層相對於Al的中子產率提升比例計算結果如表3所示,由結果知,使用Be作為抗氧化層材料時,中子產率相對於Al有明顯提升,可以獲得的中子產率為7.31E-05 n/proton-5.61E-04 n/proton。 The target T includes a heat dissipation layer 12, a base layer 13, and an active layer 14. The active layer 14 interacts with the charged particle line C to generate neutrons, and the base layer 13 supports the active layer 14. In this embodiment, the material of the active layer 14 is Li or an alloy thereof, the charged particle line C is a proton line, and the target T further includes an anti-oxidation layer 15 on the side of the active layer 14 for preventing the active layer from oxidizing, and a base layer. 13 can simultaneously suppress foaming caused by incident proton lines, and the charged particle line C sequentially passes through the anti-oxidation layer 15, the active layer 14, and the base layer 13 along the incident direction. The material of the anti-oxidation layer 15 also considers that it is not easy to be corroded by the active layer and can reduce the loss of the incident proton beam and the heat generated by the proton beam, such as at least one of Al, Ti and its alloy, or stainless steel. In this embodiment, the anti-oxidation layer 15 is a material capable of undergoing a nuclear reaction with protons at the same time, which can further increase the neutron yield while performing the above functions. At this time, the anti-oxidation layer is also a part of the active layer. Or its alloy, the energy of the incident proton beam is higher than the energy threshold of the nuclear reaction with Li and Be, which respectively produce two different nuclear reactions, 7 Li (p, n) 7 Be and 9 Be (p, n) 9 B; Be has a high melting point and good thermal conductivity. Its melting point is 1287 ° C and its thermal conductivity is 201W / (m K). Compared to Li (melting point is 181 ° C, its thermal conductivity is 71W / (m K)), The heat dissipation performance has great advantages, which further increases the life of the target, and the reaction threshold of the (p, n) nuclear reaction with protons is about 2.055 MeV. Most accelerator neutron sources using proton beams have higher energy than this. Reaction threshold, and the beryllium target is the best choice other than the lithium target. Compared with the anti-oxidation layer using other materials, such as Al, the neutron yield is improved due to the presence of Be. In this embodiment, the proton energy is 2.5MeV-5MeV, which can generate a higher active cross section with the lithium target, while not generating too many fast neutrons, and obtaining better beam quality; the thickness of the active layer 14 is 80 μ m-240 μ m, can fully react with protons, and will not be too thick to cause energy deposition and affect the heat dissipation performance of the target; while achieving the above-mentioned effects, while ensuring lower manufacturing costs, the thickness of the anti-oxidation layer 15 is 5 μm -25 μm . In the comparative test, Monte Carlo software was used to simulate 2.5MeV, 3MeV, 3.5MeV, 4MeV, 4.5MeV, and 5MeV proton beams, which were sequentially injected into the anti-oxidation layer 15 from the direction perpendicular to the active surface of the target T. Layer 14 (Li) and base layer 13 (Ta, which will be described in detail later), the material of the anti-oxidation layer 15 is compared with Al and Be, and the thickness of the anti-oxidation layer 15 is 5 μm , 10 μm , 15 μm , 20 μm , 25 μm , the thickness of the active layer 14 is 80 μm , 120 μm , 160 μm , 200 μm , 240 μm , and the thickness of the base layer 12 has almost no effect on the neutron yield It can be adjusted according to actual conditions, and the results of the neutron yield (ie, the number of neutrons produced by each proton) are shown in Tables 1 and 2. The calculation results of the neutron yield improvement ratio of the anti-oxidation layer relative to Al using Be as the lithium target are shown in Table 3. From the results, it is known that when Be is used as the anti-oxidation layer material, the neutron yield is significantly improved relative to Al. The neutron yield that can be obtained is 7.31E-05 n / proton-5.61E-04 n / proton.
散熱層12由導熱材料(如Cu、Fe、Al等導熱性能好的材料)或既能導熱又能抑制發泡的材料製成;基座層13由抑制發泡的材料製成;抑制發泡的材料或既能導熱又能抑制發泡的材料包括Fe、Ta或V中的至少一種。散熱層可以有多種構造,如為平板狀,本實施例中,散熱層12包括管狀件121及支撐件122,管狀件121和支撐件122的材料都為Cu,具有較好的散熱性能且成本較低,管狀件121由多個管並排組成並通過支撐件122進行定位安裝,支撐件122通過螺栓或螺釘等連接件固定到緩速體22內或加速管111端部,可以理解,還可以採用其他可拆卸的連接,便於更換靶材。管的構造增大了散熱面積,提升了散熱效果,有助於延長靶材的壽命。散熱層12還具有供冷卻介質流通的冷卻通道P,本實施例中,冷卻介質為水,組成管狀件121的管內部至少部分形成冷卻通道P,冷卻介質流經 管的內部帶走其熱量,管內部作為冷卻通道,進一步增強了散熱效果,延長靶材壽命。管的形狀、個數及大小根據實際靶的尺寸決定,圖中僅示意性地畫出了4個圓管,可以理解,其也可以為方管、多邊形管、橢圓管等及其組合;相鄰的管可以是緊挨的使其外表面相互接觸,也可以是間隔開的;管的內孔橫截面形狀也可以是多樣的,如圓形、多邊形、橢圓形等,不同的橫截面還可以具有不同的形狀。由於管狀件在實際製造中每個管的直徑較小,且內部有冷卻通道,常規的生產工藝難度較大,本實施例中採用增材製造來獲得管狀件,方便微小結構和複雜結構的成型。首先對管狀件進行三維建模,將管狀件的三維模型資料登錄到電腦系統中,並分層成二維切片資料,通過電腦控制的增材製造系統將原材料(如銅粉)進行逐層製造,疊加後最終獲得三維產品。 The heat dissipation layer 12 is made of a thermally conductive material (such as Cu, Fe, Al and other materials with good thermal conductivity) or a material that can conduct heat and suppress foaming; the base layer 13 is made of a foam suppressing material; foam suppressing The material or material that can both conduct heat and suppress foaming includes at least one of Fe, Ta or V. The heat dissipation layer can have various structures, such as a flat plate. In this embodiment, the heat dissipation layer 12 includes a tubular member 121 and a support member 122. The material of the tubular member 121 and the support member 122 is Cu, which has good heat dissipation performance and cost. Lower, the tubular member 121 is composed of multiple tubes side by side and is positioned and installed by the support member 122. The support member 122 is fixed to the retarder 22 or the end of the acceleration tube 111 by connecting members such as bolts or screws. It can be understood that Use other detachable connections for easy target replacement. The structure of the tube increases the heat dissipation area, improves the heat dissipation effect, and helps extend the life of the target. The heat radiating layer 12 also has a cooling channel P through which a cooling medium flows. In this embodiment, the cooling medium is water, and the cooling channel P is formed at least partially inside the tube constituting the tubular member 121. The cooling medium flows through the inside of the tube to take away its heat. The inside acts as a cooling channel, which further enhances the heat dissipation effect and extends the target life. The shape, number and size of the tubes are determined according to the size of the actual target. In the figure, only four circular tubes are schematically drawn. It can be understood that they can also be square tubes, polygonal tubes, oval tubes, etc. and their combinations; Adjacent tubes can be close to each other so that their outer surfaces are in contact with each other, or they can be spaced apart. The cross-sectional shape of the inner hole of the tube can also be various, such as circular, polygonal, oval, etc. Different cross sections are also Can have different shapes. Because the diameter of each tube in the actual manufacturing of the tubular member is small, and there are cooling channels inside, the conventional production process is difficult. In this embodiment, additive manufacturing is used to obtain the tubular member, which facilitates the molding of microstructures and complex structures. . First, three-dimensional modeling of the tubular part, registration of the three-dimensional model data of the tubular part into the computer system, and layering into two-dimensional slice data, and the raw materials (such as copper powder) are manufactured layer by layer through a computer-controlled additive manufacturing system. , And finally obtain a three-dimensional product after superimposing.
基座層13採用Ta製成時,具有一定的散熱效果同時能夠減少起泡,抑制質子與Li發生非彈性散射而釋放γ,及阻止多餘的質子通過靶材;本實施例中,基座層13的材料為Ta-W合金,在保持上述Ta的優良性能的同時能明顯地改善純鉭強度低、熱傳導性差的劣勢,使得作用層14發生核反應產生的熱量能由基座層及時傳導出去,此時,散熱層也可以至少部分與基座層採用相同的材料或一體構造。Ta-W合金中W的重量百分比為2.5%-20%,以保證基座層抑制發泡的特性,同時基座層具有更高的強度和熱傳導性,進一步延長靶材使用壽命。採用粉末冶金、鍛造、壓製等將Ta-W合金(如Ta-2.5wt%W、Ta-5.0wt%W、Ta-7.5wt%W、Ta-10wt%W、Ta-12wt%w、Ta-20wt%W等)製成板狀的基座層13,在質子線能量為1.881MeV-10MeV,基座層的厚度至少為50μm,以充分吸收多餘的質子。 When the base layer 13 is made of Ta, it has a certain heat dissipation effect and can reduce foaming, inhibit the inelastic scattering of protons and Li to release γ, and prevent excess protons from passing through the target; in this embodiment, the base layer The material of 13 is a Ta-W alloy, which can obviously improve the disadvantages of low strength and poor thermal conductivity of pure tantalum while maintaining the excellent properties of Ta, so that the heat generated by the nuclear reaction of the active layer 14 can be conducted away from the base layer in time. At this time, the heat dissipation layer may also be made of the same material or integrated structure as the base layer at least in part. The weight percentage of W in the Ta-W alloy is 2.5% -20% to ensure that the base layer suppresses foaming characteristics, and at the same time, the base layer has higher strength and thermal conductivity, which further extends the target service life. Ta-W alloys (such as Ta-2.5wt% W, Ta-5.0wt% W, Ta-7.5wt% W, Ta-10wt% W, Ta-12wt% w, Ta- 20wt% W, etc.) to make a plate-like base layer 13 with a proton energy of 1.881 MeV-10 MeV and a thickness of the base layer of at least 50 μm to fully absorb excess protons.
本實施例中,靶材T的製造工藝如下:S1:將液態的鋰金屬澆注到基座層13上形成作用層14,也可以採用蒸鍍或濺射等處理,鋰和鉭之間還可以設置極薄的附著層16,附著層16的材料包括Cu、Al、Mg或Zn中的至少一種,同樣可採用蒸鍍或濺射等處理,提高基座層與作用層的附著性;S2:將基座層13與散熱層12的管狀件121進行HIP(Hot Isostatic Pressing:熱等靜壓)處理;S3:抗氧化層15同時進行HIP處理或通過其他工藝將基座層13封閉形成一個容腔和/或將作用層14包圍;S4:支撐件122與管狀件121通過焊接、壓裝等方式進行連接。 In this embodiment, the manufacturing process of the target T is as follows: S1: The liquid lithium metal is poured onto the base layer 13 to form an active layer 14, which can also be treated by evaporation or sputtering, and it can also be between lithium and tantalum. An extremely thin adhesion layer 16 is provided. The material of the adhesion layer 16 includes at least one of Cu, Al, Mg, or Zn, and can also be treated by evaporation or sputtering to improve the adhesion between the base layer and the active layer; S2: The HIP (Hot Isostatic Pressing) process is performed on the tubular member 121 of the base layer 13 and the heat dissipation layer 12; S3: The anti-oxidation layer 15 is simultaneously HIP processed or the base layer 13 is closed by other processes to form a container. The cavity and / or the active layer 14 is surrounded; S4: the support member 122 and the tubular member 121 are connected by welding, press fitting, or the like.
上述步驟S1、S2、S3和S4不分先後,如可以先將抗氧化層15與基座層13進行HIP處理或通過其他工藝將基座層13封閉形成一個容腔,再將液態的鋰金屬澆注到該容腔內形成作用層14。可以理解,支撐件122也可以省略,將多個管通過焊接或其他方式依次連接固定為一體即可。每個管上的基座層13、作用層14、抗氧化層15分別成型,再將管狀件與支撐件122定位連接,連接後各個管上形成的基座層13、作用層14、抗氧化層15的整體可能是不連續的,則需要在相鄰的管之間形成連接部17,連接部17也由基座層13、作用層14和抗氧化層15組成,整個靶材被分為多個單獨的作用部分,進一步降低了金屬抗氧化層的起泡現象,此時,S4中支撐件122與管狀件121的連接也可採用可拆卸的方式,則靶材T可以進行部分更換,延長靶材使用壽命,降低患者治療成本;可以理解,各個管上 的基座層13、作用層14、抗氧化層15也可以整體成型再連接到管狀件,這樣連接後靶材T的作用層整體是連續的,對於帶電粒子線C與靶材T發生作用是有利的,此時支撐件122與管狀件121還可以是一體通過增材製造獲得的,降低加工、裝配難度。基座層13、作用層14、抗氧化層15形成的整體在垂直于管中心線的剖面的形狀也可以是多樣的,如與管狀件連接基座層13、作用層14、抗氧化層15一側的外表面輪廓一致,本實施例中為圓弧形,增大了靶材T與帶電粒子線C作用的面積及散熱層12與基座層13接觸並傳導熱量的面積;每個管上的作用層14至少覆蓋管外周的1/4,即作用層在圓周方向與管中心線的夾角α至少為45度。 The above steps S1, S2, S3, and S4 are in no particular order. For example, the anti-oxidation layer 15 and the base layer 13 may be subjected to HIP treatment or the base layer 13 may be closed to form a cavity by other processes, and then the liquid lithium metal An active layer 14 is formed by pouring into the cavity. It can be understood that the supporting member 122 may also be omitted, and a plurality of tubes may be connected and fixed in sequence by welding or other methods. The base layer 13, the active layer 14, and the anti-oxidation layer 15 on each tube are respectively formed, and the tubular member and the support member 122 are positioned and connected. After the connection, the base layer 13, the active layer 14, and the anti-oxidation formed on each tube are formed. The entirety of layer 15 may be discontinuous, so it is necessary to form a connecting portion 17 between adjacent tubes. The connecting portion 17 is also composed of a base layer 13, an active layer 14, and an antioxidant layer 15. The entire target is divided into Multiple separate active parts further reduce the blistering phenomenon of the metal anti-oxidation layer. At this time, the connection between the support member 122 and the tubular member 121 in S4 can also be detachable, so the target T can be partially replaced. Prolong the service life of the target and reduce the cost of patient treatment; it can be understood that the base layer 13, the active layer 14, and the anti-oxidation layer 15 on each tube can also be integrally formed and then connected to the tubular member, so that the active layer of the target T after connection The whole is continuous, which is beneficial for the action of the charged particle beam C and the target T. At this time, the support member 122 and the tubular member 121 can also be obtained by additive manufacturing, reducing the difficulty of processing and assembly. The shape of the entirety of the base layer 13, the active layer 14, and the anti-oxidation layer 15 in a cross section perpendicular to the center line of the tube may also be various, such as connecting the base layer 13, the active layer 14, and the anti-oxidation layer 15 to a tubular member. The contours of the outer surface on one side are the same. In this embodiment, the outer arc shape increases the area where the target T interacts with the charged particle line C and the area where the heat dissipation layer 12 contacts the base layer 13 and conducts heat; each tube The upper active layer 14 covers at least 1/4 of the outer circumference of the tube, that is, the angle α between the active layer and the center line of the tube is at least 45 degrees.
本實施例中,支撐件122包括第一支撐部1221和第二支撐部1222,對稱設置在管狀件121的兩端,分別具有冷卻進口IN和冷卻出口OUT,冷卻通道P連通冷卻進口IN和冷卻出口OUT。冷卻通道P包括第一支撐部上的第一冷卻通道P1、第二支撐部上的第二冷卻通道P2和組成管狀件121的管內部形成的第三冷卻通道P3。冷卻介質從第一支撐部1221上的冷卻進口IN進入,通過第一冷卻通道P1同時進入組成管狀件121的各個管內部,然後通過第二支撐部上的第二冷卻通道P2從冷卻出口OUT出來。靶材T受到高能量等級的加速質子束照射溫度升高發熱,基座層和散熱層將熱量匯出,並通過流通在管狀件和支撐件內的冷卻介質將熱量帶出,從而對靶材T進行冷卻。 In this embodiment, the support member 122 includes a first support portion 1221 and a second support portion 1222, which are symmetrically disposed at both ends of the tubular member 121 and have a cooling inlet IN and a cooling outlet OUT, respectively. The cooling channel P communicates with the cooling inlet IN and the cooling. Exit OUT. The cooling channel P includes a first cooling channel P1 on the first support portion, a second cooling channel P2 on the second support portion, and a third cooling channel P3 formed inside a tube constituting the tubular member 121. The cooling medium enters from the cooling inlet IN on the first support portion 1221, and simultaneously enters each of the tubes constituting the tubular member 121 through the first cooling channel P1, and then exits from the cooling outlet OUT through the second cooling channel P2 on the second support portion. . The target T is heated by the high-temperature accelerated proton beam irradiation temperature, and the base layer and the heat dissipation layer radiate heat, and the heat is taken out by the cooling medium circulating in the tubular member and the support member, so that the target material is heated. T is cooled.
可以理解,第一冷卻通道P1和第二冷卻通道P2還可以採用其他的設置,如使得從第一支撐部1221上的冷卻進口IN進入的冷卻介質依次通過組成管狀件121的各個管內部,最後從第二支撐部上的冷卻出口 OUT出來;冷卻介質也可以不經過支撐件,而是直接進出管狀件,此時,冷卻進口IN和冷卻出口OUT可以設置在管狀件121上,各個管依次相連組成冷卻通道P,冷卻介質依次流經各個管的內部。 It can be understood that the first cooling channel P1 and the second cooling channel P2 can also adopt other settings, such as the cooling medium entering from the cooling inlet IN on the first support portion 1221 passes through the interior of each tube constituting the tubular member 121 in sequence, and finally It comes out from the cooling outlet OUT on the second supporting part; the cooling medium can also directly enter and exit the tubular member without passing through the supporting member. At this time, the cooling inlet IN and the cooling outlet OUT can be arranged on the tubular member 121, and the tubes are connected in sequence. Forming a cooling channel P, the cooling medium flows through the interior of each tube in turn.
支撐件122還可以包括連接第一、第二支撐部1221、1222的第三支撐部1223,第三支撐部1223與管狀件121連接作用層14的一側相對的另一側接觸,第三支撐部1223也可以具有組成冷卻通道P的第四冷卻通道,此時,冷卻介質可以僅通過支撐件122而不經過管狀件121的各個管內部,各個管內部與支撐件122內的冷卻通道均不連通,支撐件122內的冷卻通道可以有多種排布方式,如螺旋形,以儘量多的經過與管接觸的區域;冷卻介質還可以既經過管內部又經過支撐件的第三支撐部或者既經過管內部又經過支撐件的第一、第二和第三支撐部。 The support member 122 may further include a third support portion 1223 connecting the first and second support portions 1221 and 1222. The third support portion 1223 is in contact with the other side of the tubular member 121 on the side opposite to the connection layer 14, and the third support The portion 1223 may also have a fourth cooling channel constituting the cooling channel P. At this time, the cooling medium may pass only through the support member 122 without passing through the interior of each tube of the tubular member 121. The cooling channels in the support member 122 can be arranged in various ways, such as spiral to pass as much as possible through the area in contact with the tube; the cooling medium can also pass through the tube and the third support portion of the support member or both The first, second, and third support portions that pass through the interior of the tube and then through the support.
本實施例中,加速管111與反射體21和緩速體22之間設置第一、第二冷卻管D1、D2,第一、第二冷卻管D1、D2的一端分別與靶材T的冷卻進口IN和冷卻出口OUT連接,另一端連接到外部冷卻源。可以理解,第一、第二冷卻管還可以以其他方式設置在射束整形體內,當靶材置於射束整形體之外時,還可以取消。 In this embodiment, first and second cooling pipes D1 and D2 are disposed between the acceleration tube 111 and the reflector 21 and the retarder 22, and one end of the first and second cooling pipes D1 and D2 is respectively connected to the cooling inlet of the target T. IN and cooling outlet OUT are connected, and the other end is connected to an external cooling source. It can be understood that the first and second cooling pipes can also be arranged in the beam shaping body in other ways. When the target is placed outside the beam shaping body, it can also be cancelled.
繼續參閱圖5-圖7,冷卻通道P內可以設置1個或多個具有冷卻表面S的突出部123,以增大散熱表面和/或形成渦流,增強散熱效果,冷卻表面S為冷卻介質在冷卻通道P內流通時能夠與突出部123接觸的表面,突出部123從冷卻通道P的內壁W沿與冷卻介質流通方向D垂直或傾斜的方向突出,可以理解,突出部123也可以其他形式從冷卻通道P的內壁W突出。在與冷卻介質流通方向D垂直的方向,突出部123從冷卻通道P內壁W 延伸的最大距離L1小於在該延伸方向延伸到相對的內壁W的距離L2的一半,突出部123並不能影響冷卻介質在該冷卻通道P內的自由流通,也就是說突出部起不到將一個冷卻通道劃分成幾個基本獨立(冷卻介質互不影響)的冷卻通道的作用。 With continued reference to FIGS. 5-7, one or more protrusions 123 having a cooling surface S may be provided in the cooling channel P to increase the heat dissipation surface and / or form eddy currents to enhance the heat dissipation effect. The cooling surface S is a cooling medium in The surface that can contact the protruding portion 123 during the circulation in the cooling channel P. The protruding portion 123 protrudes from the inner wall W of the cooling channel P in a direction perpendicular or inclined to the cooling medium flow direction D. It can be understood that the protruding portion 123 can also be in other forms. It protrudes from the inner wall W of the cooling passage P. In the direction perpendicular to the cooling medium flow direction D, the maximum distance L1 of the protruding portion 123 extending from the inner wall W of the cooling channel P is less than half of the distance L2 extending in the extending direction to the opposite inner wall W. The protruding portion 123 cannot affect The free circulation of the cooling medium in the cooling channel P, that is to say, the protrusion cannot function to divide a cooling channel into several basically independent cooling channels (the cooling medium does not affect each other).
在圖5a和5b所示的冷卻通道的第一實施例中,突出部123從冷卻通道P的內壁W沿與冷卻介質流通方向D垂直的方向突出,冷卻通道P的內壁W為圓柱面,突出部123為呈直線形沿冷卻介質流通方向D延伸的條形件,可以理解,冷卻通道P的內壁W可以為其他形狀,突出部123還可以呈螺旋形或其他形狀從冷卻通道P的內壁W沿冷卻介質流通方向延伸。圖中突出部為10個且沿內壁W周向平均分佈,可以理解,突出部也可以為其他個數或僅設置在與作用層或基座層接觸的冷卻通道內壁W,至少2個相鄰突出部的形狀和/或突出長度也可以不同。突出部123在垂直於冷卻介質流通方向D的橫截面形狀可以是矩形、梯形、三角形等;不同橫截面形狀或大小也可以不同,如在冷卻介質流通方向呈脈衝狀、鋸齒狀或波浪狀。突出部123的冷卻表面S上設置子突出部1231,本實施例中,子突出部1231在垂直於冷卻介質流通方向D的橫截面形狀為鋸齒狀,並沿冷卻介質流通方向D延伸,可以理解,子突出部也可以具有各種不同的構造,只要能增加散熱表面即可;本實施例中,子突出部1231僅示意性地設置在突出部123的其中一個冷卻表面上,可以理解,子突出部1231還可以設置在突出部123的任意其他冷卻表面上。 In the first embodiment of the cooling channel shown in FIGS. 5a and 5b, the protruding portion 123 protrudes from the inner wall W of the cooling channel P in a direction perpendicular to the cooling medium flow direction D, and the inner wall W of the cooling channel P is a cylindrical surface. The protruding portion 123 is a bar extending linearly along the cooling medium flow direction D. It can be understood that the inner wall W of the cooling channel P may have other shapes, and the protruding portion 123 may also have a spiral shape or other shape from the cooling channel P. The inner wall W extends along the cooling medium flow direction. In the figure, there are 10 protrusions and they are evenly distributed along the inner wall W. It can be understood that the protrusions can also be other numbers or only provided on the inner wall W of the cooling channel that is in contact with the active layer or the base layer. Adjacent protrusions may also have different shapes and / or protrusion lengths. The cross-sectional shape of the protrusion 123 in a direction perpendicular to the cooling medium flow direction D may be rectangular, trapezoidal, triangular, and the like; different cross-sectional shapes or sizes may also be different, such as pulsating, zigzag, or wavy in the cooling medium flow direction. Sub-protrusions 1231 are provided on the cooling surface S of the protrusions 123. In this embodiment, the cross-sectional shape of the sub-protrusions 1231 perpendicular to the cooling medium flow direction D is zigzag and extends along the cooling medium flow direction D. It can be understood The sub-protrusions can also have various structures as long as they can increase the heat dissipation surface. In this embodiment, the sub-protrusions 1231 are only schematically provided on one of the cooling surfaces of the protrusions 123. It can be understood that the sub-protrusions The portion 1231 may also be provided on any other cooling surface of the protruding portion 123.
圖6a和6b所示為冷卻通道的第二實施例,下面僅描述其與第一實施例不同的地方,突出部123為在冷卻介質流通方向間隔分佈的 環,可以理解,也可以為環的至少一部分。圖中環的個數和冷卻通道的長度僅為示意,可根據實際情況進行調整。本實施例中,環的端面為垂直於冷卻介質流通方向D的平面,可以理解,其也可以為與冷卻介質流通方向D傾斜的平面或為錐形面或曲面等。 Figures 6a and 6b show a second embodiment of the cooling channel. Only the differences from the first embodiment are described below. The protrusions 123 are rings distributed at intervals in the cooling medium flow direction. It can be understood that the rings can also be ring-shaped. At least a part. The number of rings and the length of the cooling channel in the figure are only for illustration, and can be adjusted according to the actual situation. In this embodiment, the end surface of the ring is a plane perpendicular to the cooling medium flow direction D, and it can be understood that it may also be a plane inclined to the cooling medium flow direction D or a tapered surface or curved surface.
參閱圖7,冷卻通道的第三實施例中,冷卻通道P內設置至少一個第二壁124將冷卻通道P分為至少2個相互獨立的子通道P'和P",至少2個相鄰子通道中冷卻介質流通方向不同,增加散熱效率。本實施例中,第二壁124在第一實施例的基礎上為圓筒狀並穿過各突出部123,圓筒狀的第二壁124內部形成子通道P',同時在每2個相鄰的突出部123和第二壁124之間形成1個子通道P",從而圍繞子通道P'形成10個子通道P",子通道P'和至少一個子通道P"中的冷卻介質流通方向不同,至少2個相鄰的子通道P"中的冷卻介質流通方向也可以不同。可以理解,第二壁根據突出部的不同設置還可以有其他的設置方式。冷卻通道內的突出部及其上的子突出部進一步增加了製造難度,因此,突出部和/或第二壁可以採用單獨成型然後插入管內進行定位,或與管一體通過增材製造獲得。 Referring to FIG. 7, in a third embodiment of the cooling channel, at least one second wall 124 is provided in the cooling channel P to divide the cooling channel P into at least two independent sub-channels P ′ and P ″, and at least two adjacent sub-channels. The cooling medium flows in different directions in the channel, which increases heat dissipation efficiency. In this embodiment, the second wall 124 is cylindrical and passes through each of the protrusions 123 on the basis of the first embodiment, inside the cylindrical second wall 124 A sub-channel P 'is formed, and at the same time, a sub-channel P "is formed between every 2 adjacent protrusions 123 and the second wall 124, thereby forming 10 sub-channels P" around the sub-channel P', and at least The flow direction of the cooling medium in one sub-channel P "is different, and the flow direction of the cooling medium in at least two adjacent sub-channels P" may also be different. It can be understood that the second wall may have other Setting method: The protrusions in the cooling channel and the sub-protrusions on it further increase the manufacturing difficulty, therefore, the protrusions and / or the second wall can be formed separately and then inserted into the tube for positioning, or integrated with the tube through the additive Manufacturing obtained.
可以理解,還可以將散熱層12同時作為基座層13,此時,散熱層12至少部分由既能導熱又能抑制發泡的材料製成,如採用Ta或Ta-W合金製成的管狀件121和Cu製成的支撐件122,作用層14通過蒸鍍或濺射等工藝與Ta或Ta-W合金管連接,Ta或Ta-W合金管同時作為基座層12和散熱層13。本實施例中,靶材T整體呈矩形板狀;可以理解,靶材T還可以為圓板狀,第一支撐部和第二支撐部組成整個圓周或圓周的一部分,此時管的長度可以不同;靶材T也可以為其他固體形狀;靶材T還可以相對加速器或 射束整形體是可運動的,以方便換靶或使粒子線與靶材均勻作用。作用層14也可以使用液狀物(液體金屬)。 It can be understood that the heat dissipation layer 12 can also be used as the base layer 13 at this time. At this time, the heat dissipation layer 12 is at least partially made of a material that can conduct heat and suppress foaming, such as a tube made of Ta or Ta-W alloy. The support 121 is made of the piece 121 and Cu, and the active layer 14 is connected to the Ta or Ta-W alloy tube through a process such as evaporation or sputtering. The Ta or Ta-W alloy tube serves as the base layer 12 and the heat dissipation layer 13 at the same time. In this embodiment, the target T has a rectangular plate shape as a whole; it can be understood that the target T may also have a circular plate shape, and the first support portion and the second support portion constitute the entire circumference or a part of the circumference. At this time, the length of the tube may be Different; the target T can also be other solid shapes; the target T can also be movable relative to the accelerator or the beam shaper, in order to facilitate the change of the target or make the particle line and the target uniform. The active layer 14 may be a liquid (liquid metal).
可以理解,本發明的靶還可以應用於其他醫療和非醫療領域的中子產生裝置,只要其中子的產生是基於粒子線與靶材的核反應,則靶材的材料也基於不同的核反應有所區別;還可以應用於其他粒子線產生裝置。 It can be understood that the target of the present invention can also be applied to other neutron generating devices in the medical and non-medical fields. As long as the generation of neutrons is based on the nuclear reaction between the particle line and the target, the target material is also based on different nuclear reactions. Difference; it can also be applied to other particle beam generating devices.
本發明中的“管狀件”指的是多個單獨的管排列並通過連接件或連接工藝進行連接組成的整體,由一個或多個板狀件形成或組合形成中空部得到的帶中空部的物體不能理解為本發明的管狀件。 The "tubular member" in the present invention refers to a whole formed by arranging a plurality of individual tubes and connecting them through a connecting member or a connecting process, and forming a hollow portion with one or more plate-shaped members or combining them to form a hollow portion. An object cannot be understood as a tubular piece of the invention.
儘管上面對本發明說明性的具體實施方式進行了描述,以便於本技術領域的技術人員理解本發明,但應該清楚,本發明不限於具體實施方式的範圍,對本技術領域的普通技術人員來講,只要各種變化在所附的權利要求限定和確定的本發明的精神和範圍內,這些變化是顯而易見的,都在本發明要求保護的範圍之內。 Although the illustrative specific embodiments of the present invention have been described above so that those skilled in the art can understand the present invention, it should be clear that the present invention is not limited to the scope of the specific embodiments, and for those of ordinary skill in the art, As long as various changes are within the spirit and scope of the present invention as defined and determined by the appended claims, these changes are obvious and all fall within the scope of protection of the present invention.
Claims (10)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ??201611213272.5 | 2016-12-23 | ||
| ??201621425423.9 | 2016-12-23 | ||
| CN201611213272 | 2016-12-23 | ||
| CN201621425423 | 2016-12-23 | ||
| CN201710389061.5A CN108934120B (en) | 2017-05-26 | 2017-05-26 | Target for neutron ray generating device and neutron capturing treatment system |
| ??201710389061.5 | 2017-05-26 | ||
| CN201720600026.9U CN206835439U (en) | 2017-05-26 | 2017-05-26 | Target and neutron capture treatment system for neutron beam generating apparatus |
| ??201720600026.9 | 2017-05-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201824962A true TW201824962A (en) | 2018-07-01 |
| TWI649012B TWI649012B (en) | 2019-01-21 |
Family
ID=63639901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW106128754A TWI649012B (en) | 2016-12-23 | 2017-08-24 | Target and neutron capture treatment system for neutron beam generating device |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI649012B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109496051A (en) * | 2018-12-21 | 2019-03-19 | 北京中百源国际科技创新研究有限公司 | It is a kind of for increasing the slowing down device of low number of neutrons |
| RU2774289C1 (en) * | 2018-10-26 | 2022-06-16 | Джапан Тобакко Инк. | Body and flavouring inhalation apparatus equipped therewith |
| TWI786791B (en) * | 2019-04-17 | 2022-12-11 | 中國商中硼(廈門)醫療器械有限公司 | Beam Shapers for Neutron Capture Therapy Systems |
| TWI824743B (en) * | 2021-09-26 | 2023-12-01 | 大陸商中硼(廈門)醫療器械有限公司 | Neutron capture therapy system and target material installation method for particle beam generating device |
| US12059031B2 (en) | 2018-10-26 | 2024-08-13 | Japan Tobacco Inc. | Housing and flavor aspirator provided with same |
| US12238850B2 (en) | 2021-07-16 | 2025-02-25 | Neuboron Therapy System Ltd. | Target material for particle beam generation apparatus |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4076990A (en) * | 1975-10-08 | 1978-02-28 | The Trustees Of The University Of Pennsylvania | Tube target for fusion neutron generator |
| JP2006196353A (en) * | 2005-01-14 | 2006-07-27 | Hitachi Ltd | Accelerator neutron source and boron neutron capture therapy system using the same |
| JP5054335B2 (en) * | 2006-07-18 | 2012-10-24 | 株式会社日立製作所 | Medical device for boron neutron capture therapy |
| JP6113453B2 (en) * | 2012-07-13 | 2017-04-12 | 株式会社八神製作所 | Target for neutron generator and manufacturing method thereof |
| JP6243293B2 (en) * | 2014-05-20 | 2017-12-06 | 住友重機械工業株式会社 | Neutron capture therapy device and transmutation device |
| JP6605221B2 (en) * | 2015-03-31 | 2019-11-13 | 住友重機械工業株式会社 | Neutron capture therapy device |
-
2017
- 2017-08-24 TW TW106128754A patent/TWI649012B/en active
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2774289C1 (en) * | 2018-10-26 | 2022-06-16 | Джапан Тобакко Инк. | Body and flavouring inhalation apparatus equipped therewith |
| US12059031B2 (en) | 2018-10-26 | 2024-08-13 | Japan Tobacco Inc. | Housing and flavor aspirator provided with same |
| US12439968B2 (en) | 2018-10-26 | 2025-10-14 | Japan Tobacco Inc. | Housing and flavor aspirator provided with same |
| CN109496051A (en) * | 2018-12-21 | 2019-03-19 | 北京中百源国际科技创新研究有限公司 | It is a kind of for increasing the slowing down device of low number of neutrons |
| TWI786791B (en) * | 2019-04-17 | 2022-12-11 | 中國商中硼(廈門)醫療器械有限公司 | Beam Shapers for Neutron Capture Therapy Systems |
| RU2833532C2 (en) * | 2021-07-16 | 2025-01-23 | Нойборон Терапи Систем Лтд. | Target material for particle beam generating device |
| US12238850B2 (en) | 2021-07-16 | 2025-02-25 | Neuboron Therapy System Ltd. | Target material for particle beam generation apparatus |
| US12356537B2 (en) | 2021-07-16 | 2025-07-08 | Neuboron Therapy System Ltd. | Neutron capture therapy system |
| TWI824743B (en) * | 2021-09-26 | 2023-12-01 | 大陸商中硼(廈門)醫療器械有限公司 | Neutron capture therapy system and target material installation method for particle beam generating device |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI649012B (en) | 2019-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7332736B2 (en) | Targets for neutron capture therapy systems and particle beam generators | |
| JP7464672B2 (en) | Beam shapers for neutron capture therapy. | |
| CN108926784B (en) | Neutron capture treatment system and target for particle beam generating device | |
| TWI581821B (en) | A beam shaping assembly for neutron capture therapy | |
| CN104548388B (en) | Beam Shapers for Neutron Capture Therapy | |
| TWI687249B (en) | Neutron Capture Therapy System | |
| CN108926781B (en) | Neutron capture treatment system and target for particle beam generating device | |
| CN110180095B (en) | Beam shaping body for neutron capture therapy | |
| CN205460520U (en) | Beam shaper for neutron -capture therapy | |
| CN109381802A (en) | Neutron capture treatment system and target for particle beam generating apparatus | |
| WO2019114307A1 (en) | Neutron capture therapy system | |
| TW201824962A (en) | A target and neutron capture treatment system that is used for neutron line to produce device | |
| CN112933422A (en) | Target material for neutron line generation device | |
| CN207856090U (en) | Neutron capture treatment system and target for particle beam generating apparatus | |
| CN108926782B (en) | Target for neutron ray generating device and neutron capturing treatment system | |
| WO2019029483A1 (en) | Neutron capture therapy system and target material for use with particle beam production device | |
| CN109420261B (en) | Neutron capture therapy system | |
| CN207640822U (en) | Neutron capture treatment system and target for particle beam generating apparatus | |
| CN207640821U (en) | Neutron capture treatment system and target for particle beam generating apparatus | |
| TW201822837A (en) | Neutron capturing therapy system and target material for use in particle beam generating device | |
| CN108236760B (en) | neutron capture therapy system | |
| CN108934120B (en) | Target for neutron ray generating device and neutron capturing treatment system | |
| CN108926783B (en) | Neutron capture treatment system and target for particle beam generating device |